1 Min Read
Oct 13 (Reuters) - Protagonist Therapeutics Inc
* Press release - protagonist therapeutics to present phase 1 clinical and preclinical data on ptg-100 at ueg week, vienna Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.